Moratoire de deux ans sur remboursement de l’homéopathie

This French National Assembly bill proposes a two-year pause on public reimbursement of homeopathic treatments. Homeopathy is a practice whose effectiveness is widely disputed by scientific bodies, and the debate centres on whether public health insurance should continue to cover it. The metadata does not reveal the bill's exact provisions, so this summary is based on its title and type only. If adopted, the measure would affect patients who currently have homeopathic remedies partly reimbursed by the national health insurance system, as well as pharmacists, homeopathic practitioners and pharmaceutical manufacturers. Health authorities and the public health budget would also be directly concerned.